Thymosin alpha-1 combined with interferon shifted the Th1/Th2 cytokine balance in hepatitis C patients toward Th1 (virus-fighting) dominance, while interferon alone had limited effect on this balance.
Immune mode shiftCombined thymosin alpha-1 + IFN shifted immune balance from Th2 (infection-permissive) to Th1 (virus-fighting) — the key to clearing hepatitis C
What the researchers found
Thymosin alpha-1 + IFN-alpha shifted Th1/Th2 balance toward Th1 dominance (increased IFN-γ/IL-2, decreased IL-4/IL-10) in HCV patient PBMCs, while IFN-alpha alone produced only partial Th1 enhancement.
Why it matters
Hepatitis C persistence is linked to Th2-dominant immune profiles. A therapeutic that shifts this balance toward Th1 could help achieve viral clearance, explaining thymosin alpha-1's clinical benefit.
How the study worked
In-vitro study using peripheral blood mononuclear cells from chronic hepatitis C patients. Thymosin alpha-1, IFN-alpha, and their combination tested for Th1 and Th2 cytokine production.
What this study cannot tell us
In-vitro study; immune cell behavior in culture may differ from in vivo. Patient heterogeneity. The degree of Th1 shift needed for clinical benefit is uncertain.
How to read the evidence
Preliminary in-vitro evidence using patient cells, providing a mechanistic explanation for thymosin alpha-1's clinical benefit in hepatitis C.
When this study was published
Published in 2001. While HCV is now treated with direct-acting antivirals, thymosin alpha-1's Th1-promoting mechanism remains relevant for other chronic infections.
The bigger picture
Many chronic infections persist because the immune system is stuck in the wrong mode (Th2). Thymosin alpha-1's ability to repolarize immunity toward Th1 has implications beyond hepatitis for any infection requiring cellular immunity.
Questions still open
- Does the Th1 shift predict clinical response to thymosin alpha-1 therapy?
- Could thymosin alpha-1 benefit other chronic viral infections with Th2 dominance?
- Is the Th1 shift sustained after treatment stops?
Common questions
What is the Th1/Th2 balance?
Why does this matter if hepatitis C is now curable?
Read the original research
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.
Journal of viral hepatitis, 8(3), 194-201
Citation
Andreone, P; Cursaro, C; Gramenzi, A; Margotti, M; Ferri, E; Talarico, S; Biselli, M; Felline, F; Tuthill, C; Martins, E; Gasbarrini, G; Bernardi, M. (2001). In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C.. Journal of viral hepatitis, 8(3), 194-201.